PTPA and neoplasm: Reudiger et al. [22] have shown that these mutations greatly interrupt the interactions of the scaffold subunit with either B subunit alone (Glu64-Asp and Glu64-Gly), or with both B and C subunits (Arg418–Trp, and the deletion mutant), thus abolishing specific PP-2A activity and leading to tumor formation.